AI drug discovery

Peptides

The New Peptide Pipeline: How AI Is Quietly Rewiring Drug Discovery

Computational design is pushing peptide therapeutics into oncology, infectious disease, and antimicrobial resistance. The early signals are real — and the caveats matter.

Peptides

Peptides Go Programmable: AI Diffusion Models Are Designing the Next Therapeutic Wave

A new class of generative models is treating peptide design like a search problem — and the early outputs hint at a faster, more targeted pipeline behind a quarter of all pharma.